Skip to content

Clinical study for the choice of laparoscopic lymph node dissection approach in splenic region of advanced gastric cancer

Clinical study for the choice of laparoscopic lymph node dissection approach in splenic region of advanced gastric cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026333
Enrollment
Unknown
Registered
2019-09-30
Start date
2019-09-25
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Mixed approach group:The splenic hilar lymph nodes were dissected by the mixed approach
Left approach group:The splenic hilar lymph nodes were dissected by the left approach
Medial approach group:The splenic hilar lymph nodes were dissected by the medial approach

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Diagnosed with gastric cancer by pre-operative gastroscopy biopsy; 3. Patients undergo radical surgery; 4. Elective surgery; 5. Patients undergo laparoscopic total gastrectomy; 6. BMI between 18-30kg/m2; 7. Patients without other primary tumors; 9. Patients fully understand the aim of this trial,volunteer to be in and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with distant metastases, tumor infiltrating to adjacent organ or recurrent cases; 2. Patients underwent emergent surgery due to perforation, hemorrhage, intestinal obstruction, etc.; 3. Patients with severe cardiac, pulmonary, hepatic or renal comorbities and hence could tolerate laparoscopic surgery; 4. Patients with bad general condition and do not improve before surgery; 5. Intraoperative tumor intraperitoneal implantation spread or distant metastasis was found in patients; 6. Patients received neoadjuvant chemoradiotherapy before surgery 7. The patient's clinical history and pathological data are incomplete.

Design outcomes

Primary

MeasureTime frame
Splenic area lymph node dissection time;Intraoperative adverse events;

Secondary

MeasureTime frame
time of the operation;the morbidity rate;The number of lymph nodes in group 4Sb was dissected;The number of lymph nodes in group 10 was dissected;The number of lymph nodes in group 11d was dissected;postoperative hospital stays;gastrointestinal function recovery;

Countries

China

Contacts

Public ContactJian Zhang

Affiliated Hospital of Qingdao University

drjianzhang@126.com+86 18661801310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026